Anteris Technologies Global Corp. Common Stock (AVR)

Anteris Technologies Global Corp. Common Stock (AVR) is a Medical Devices company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $629M; returns 1 day -2.2%, 1 week -3.0%, 1 year +5.0%.

Anteris Technologies Global Corp. (AVR) is a structural heart company focused on developing and commercializing medical devices for aortic stenosis, a life-threatening condition caused by the narrowing of the aortic valve. Their lead product is the DurAVR Transcatheter Heart Valve (THV), designed to mimic a healthy human aortic valve, using ADAPT tissue technology for anti-calcification.

Groups AVR belongs to

• Medical Devices
• Healthcare Equipment
• Biotechnology
• Healthcare
• Cardiovascular Therapies
• Life Sciences
• Regenerative Medicine
• Biologics

AVR financial model: income statement, cash flow and balance sheet